SRS11-92 demonstrates significant neuroprotective effects, reducing oxidative stress and senescence in Alzheimer’s disease models, suggesting a promising therapeutic approach.
SRS11-92 exerts significant neuroprotective effects, attributable to reducing stress-induced senescence via activating Nrf2/HO-1 and constraining NF-κB signalling.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: